Czech Republic – Medicinal product of ATC group L03AB13 with the active substance PEGINTERFERON BETA-1A

By: Pardubice Region Hospital, a.s.📍 Czech RepublicOpen

Key Information

ReferenceGB-801771-2026
DeadlineDec 18, 2026 12:00 AM
Estimated ValueCZK 6,064,000.00
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryCzech Republic
AddressKyivská 44, Pardubice, 53003, Czech Republic
PublishedNov 18, 2026

Description

2. Procedure2.1.ProcedureTitle: Medicinal product of ATC group L03AB13 with the active substance PEGINTERFERON BETA-1ADescription: The subject of the performance of the public contract is the provisio...

Full details are available after unlocking this tender.